Vivos Therapeutics, Inc.

Ticker

VVOS

Website

Sector

Healthcare

Tearsheet

Why Invest

Published Study reporting one in four patients show no symptoms of Obstructive Sleep Apnea After Vivos Treatment. 17 Published Studies show a mean reduction in AHI scores by 67.4% in patients with varying degrees of Obstructive Sleep apnea. FDA registrations and clearances since 2009. Marketplace acceptance – over 19,000 patients treated – over 1,250 Dentists trained

  

  1. More than 1 billion people worldwide have obstructive sleep apnea. 40+ comorbid with unhealthy sleep and sleep apnea. Limited access and cost of diagnosis to get a sleep lab.

  2. Modern medicine is not adequate enough to solve this solution

  3. “A decade ahead of anyone who would want to come into this market and compete”

  4. Cash is up $10m YoY